作者: Massimo Clementi , Roberto Burioni
DOI:
关键词:
摘要: The present invention relates to the monoclonal antibody e20 or a functional fragment thereof as medicament for therapeutic treatment and prevention of HCV infections. is able bind all known genotypes exhibits strong neutralising activity against virus, in particular towards Ia, Ib, 2a, 4. A pharmaceutical composition also described infections, which comprises thereof, pharmaceutically acceptable excipients, carriers diluents.